Scott Hutton
Vermogen: 810 288 $ op 31-05-2026
Vermogen: 810 288 $ op 31-05-2026
Scott Hutton is currently President, Chief Executive Officer & Director at Biodesix, Inc. since 2020.
Mr. Hutton serves as Independent Director at Eximis Surgical, Inc. since 2018.
Mr. Hutton is Director & Secretary at The Coalition for 21st Century Medicine.
Mr. Hutton is a Member of Sigma Chi Corp., Purdue Delta Delta Chapter.
Formerly, Mr. Hutton was Director at Colorado BioScience Association from 2011 to 2013.
Mr. Hutton was Senior VP & GM-Vascular Intervention Division at Spectranetics LLC in 2017.
Mr. Hutton was Vice President & General Manager at Medtronic Plc.
Mr. Hutton completed undergraduate education at Purdue University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
BIODESIX, INC. 0,62% | 04-03-2026 | 49.650 ( 0,62% ) | 810 288 $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| BIODESIX, INC. | Algemeen Directeur | 01-01-2020 |
Eximis Surgical, Inc.
Eximis Surgical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures surgical devices | Directeur/Bestuurslid | 01-02-2018 |
Sigma Chi Corp.
Sigma Chi Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a social fraternity | Corporate Officer/Principal | - |
The Coalition for 21st Century Medicine
The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine is a collaborative organization representing diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists, and patient advocacy groups. The non-profit company is based in Arlington, VA. It is dedicated to advancing the development, commercialization, and adoption of molecular and genomic diagnostic technologies that enable personalized medicine, improve patient outcomes, and reduce healthcare costs. The coalition engages with policymakers to shape regulatory, reimbursement, and intellectual property policies supporting innovation in diagnostic medicine, advocates for balanced regulatory frameworks, opposes burdensome regulations on laboratory-developed tests, and promotes patent predictability. It addresses issues such as patent eligibility, Medicare payment modernization, and expanded coverage for advanced diagnostic assays, and regularly submits comments, position statements, and amicus briefs to protect intellectual property rights and improve patient access. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, Patrick F. Terry. | Directeur/Bestuurslid | - |
| Bedrijven | Functie | Einde |
|---|---|---|
| SPECTRANETICS CORP | Corporate Officer/Principal | 01-12-2017 |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Operates as a association for life sciences | Directeur/Bestuurslid | 01-04-2013 |
| MEDTRONIC PLC | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Spectranetics LLC
Spectranetics LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets medical devices for cardiovascular surgeries | Health Technology |
Biodesix, Inc.
Biodesix, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic research and clinical trial testing services & engages in discovery, development and commercialization of therapeutics | Health Services |
Purdue University
Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sigma Chi Corp.
Sigma Chi Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a social fraternity | Commercial Services |
Colorado BioScience Association
Colorado BioScience Association Miscellaneous Commercial ServicesCommercial Services Operates as a association for life sciences | Commercial Services |
The Coalition for 21st Century Medicine
The Coalition for 21st Century Medicine Miscellaneous Commercial ServicesCommercial Services The Coalition for 21st Century Medicine is a collaborative organization representing diagnostic technology companies, clinical laboratories, researchers, physicians, venture capitalists, and patient advocacy groups. The non-profit company is based in Arlington, VA. It is dedicated to advancing the development, commercialization, and adoption of molecular and genomic diagnostic technologies that enable personalized medicine, improve patient outcomes, and reduce healthcare costs. The coalition engages with policymakers to shape regulatory, reimbursement, and intellectual property policies supporting innovation in diagnostic medicine, advocates for balanced regulatory frameworks, opposes burdensome regulations on laboratory-developed tests, and promotes patent predictability. It addresses issues such as patent eligibility, Medicare payment modernization, and expanded coverage for advanced diagnostic assays, and regularly submits comments, position statements, and amicus briefs to protect intellectual property rights and improve patient access. The company was founded by Howard C. Birndorf, Jeffrey N. Peterson, M. Kathleen Behrens Wilsey, Patrick F. Terry. | Commercial Services |
Medtronic Plc
Medtronic Plc Medical SpecialtiesHealth Technology Provides medical technology services | Health Technology |
Eximis Surgical, Inc.
Eximis Surgical, Inc. Medical SpecialtiesHealth Technology Develops and manufactures surgical devices | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau